242 related articles for article (PubMed ID: 8168036)
1. p53 expression in pseudoepitheliomatous hyperplasia, keratoacanthoma, and squamous cell carcinoma of skin.
Lee YS; Teh M
Cancer; 1994 May; 73(9):2317-23. PubMed ID: 8168036
[TBL] [Abstract][Full Text] [Related]
2. Expression of p53 protein in benign and malignant epidermal pathologic conditions.
Helander SD; Peters MS; Pittelkow MR
J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):741-8. PubMed ID: 8227547
[TBL] [Abstract][Full Text] [Related]
3. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors.
Cain CT; Niemann TH; Argenyi ZB
Am J Dermatopathol; 1995 Aug; 17(4):324-31. PubMed ID: 8600793
[TBL] [Abstract][Full Text] [Related]
4. Is keratoacanthoma a variant of squamous cell carcinoma. New insights into an old controversy ... soon?
LeBoit PE
Am J Dermatopathol; 1995 Aug; 17(4):319-20. PubMed ID: 8600791
[No Abstract] [Full Text] [Related]
5. Expression of CD95 (Fas) in sun-exposed human skin and cutaneous carcinomas.
Filipowicz E; Adegboyega P; Sanchez RL; Gatalica Z
Cancer; 2002 Feb; 94(3):814-9. PubMed ID: 11857317
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 oncogene expression in keratoacanthoma and squamous cell carcinoma.
Stephenson TJ; Royds J; Silcocks PB; Bleehen SS
Br J Dermatol; 1992 Dec; 127(6):566-70. PubMed ID: 1476915
[TBL] [Abstract][Full Text] [Related]
7. Two distinct p53 immunohistochemical patterns in human squamous-cell skin cancer, precursors and normal epidermis.
Ren ZP; Pontén F; Nistér M; Pontén J
Int J Cancer; 1996 Jun; 69(3):174-9. PubMed ID: 8682583
[TBL] [Abstract][Full Text] [Related]
8. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma.
Kerschmann RL; McCalmont TH; LeBoit PE
Arch Dermatol; 1994 Feb; 130(2):181-6. PubMed ID: 8304756
[TBL] [Abstract][Full Text] [Related]
9. Differentiating cutaneous squamous cell carcinoma and pseudoepitheliomatous hyperplasia by multiplex qRT-PCR.
Su A; Ra S; Li X; Zhou J; Binder S
Mod Pathol; 2013 Nov; 26(11):1433-7. PubMed ID: 23702732
[TBL] [Abstract][Full Text] [Related]
10. 'Anti-metastatic' nm23 gene product expression in keratoacanthoma and squamous cell carcinoma.
Stephenson TJ; Royds JA; Bleehen SS; Silcocks PB; Rees RC
Dermatology; 1993; 187(2):95-9. PubMed ID: 8358113
[TBL] [Abstract][Full Text] [Related]
11. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma.
Batinac T; Zamolo G; Coklo M; Hadzisejdic I; Stemberger C; Zauhar G
Pathol Res Pract; 2006; 202(8):599-607. PubMed ID: 16781827
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical detection of p53 in epidermal proliferations overlying dermatofibromas.
Haerslev T; Rossen K; Hou-Jensen K; Jacobsen GK
Acta Derm Venereol; 1995 May; 75(3):187-9. PubMed ID: 7653177
[TBL] [Abstract][Full Text] [Related]
13. Retinoblastoma gene expression in human non-melanoma skin cancer.
Edwards MJ; Thomas RC; Wong YL
J Cutan Pathol; 2003 Sep; 30(8):479-85. PubMed ID: 12950498
[TBL] [Abstract][Full Text] [Related]
14. [Elevated p53 protein expression in normal and neoplastic light-exposed epidermis].
Sutter C; Wersin R; Varnai M; Friemann J
Verh Dtsch Ges Pathol; 1994; 78():246-51. PubMed ID: 7533993
[TBL] [Abstract][Full Text] [Related]
15. Expression of p53 in the evolution of squamous cell carcinoma: correlation with the histology of the lesion.
Barzilai A; Lyakhovitsky A; Trau H; Fogel M; Huszar M
J Am Acad Dermatol; 2007 Oct; 57(4):669-76. PubMed ID: 17870432
[TBL] [Abstract][Full Text] [Related]
16. Proliferating cell nuclear antigen (PCNA) expression in pseudoepitheliomatous hyperplasia, keratoacanthoma and squamous cell carcinoma of the skin.
Li J; Lee YS
Ann Acad Med Singap; 1996 Jul; 25(4):526-30. PubMed ID: 8893923
[TBL] [Abstract][Full Text] [Related]
17. p53 protein expression in benign and malignant skin tumours.
Ro YS; Cooper PN; Lee JA; Quinn AG; Harrison D; Lane D; Horne CH; Rees JL; Angus B
Br J Dermatol; 1993 Mar; 128(3):237-41. PubMed ID: 8471506
[TBL] [Abstract][Full Text] [Related]
18. Squamous proliferations on the legs of women: Qualitative examination of histopathology, TP53 sequencing, and implications for diagnosis in a series of 30 cases.
Ko CJ; Glusac EJ; McNiff JM; Rodic N; Leffell DJ
J Am Acad Dermatol; 2017 Dec; 77(6):1126-1132.e1. PubMed ID: 28709693
[TBL] [Abstract][Full Text] [Related]
19. Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers.
Putti TC; Teh M; Lee YS
Mod Pathol; 2004 Apr; 17(4):468-75. PubMed ID: 14976535
[TBL] [Abstract][Full Text] [Related]
20. Actinic keratoacanthoma. Speculations on the nature of the lesion and the role of cellular immunity in its evolution.
Lawrence N; Reed RJ
Am J Dermatopathol; 1990 Oct; 12(5):517-33. PubMed ID: 2244666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]